JP5388555B2 - Moisturizer, anti-aging agent, antioxidant, slimming agent, whitening agent, anti-inflammatory agent, immunostimulant, external preparation for skin, functional oral composition - Google Patents

Moisturizer, anti-aging agent, antioxidant, slimming agent, whitening agent, anti-inflammatory agent, immunostimulant, external preparation for skin, functional oral composition Download PDF

Info

Publication number
JP5388555B2
JP5388555B2 JP2008310359A JP2008310359A JP5388555B2 JP 5388555 B2 JP5388555 B2 JP 5388555B2 JP 2008310359 A JP2008310359 A JP 2008310359A JP 2008310359 A JP2008310359 A JP 2008310359A JP 5388555 B2 JP5388555 B2 JP 5388555B2
Authority
JP
Japan
Prior art keywords
extract
effect
agent
added
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2008310359A
Other languages
Japanese (ja)
Other versions
JP2010132606A (en
Inventor
野乃 山村
仁美 長谷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noevir Co Ltd
Original Assignee
Noevir Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noevir Co Ltd filed Critical Noevir Co Ltd
Priority to JP2008310359A priority Critical patent/JP5388555B2/en
Publication of JP2010132606A publication Critical patent/JP2010132606A/en
Application granted granted Critical
Publication of JP5388555B2 publication Critical patent/JP5388555B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Description

本発明は、コモチシダ属(Woodwardia)植物またはその抽出物を含有する保湿剤、抗老化剤、抗酸化剤、痩身剤、美白剤、抗炎症剤、免疫賦活剤、皮膚外用剤、機能性経口組成物に関する。   The present invention relates to a moisturizer, an anti-aging agent, an antioxidant, a slimming agent, a whitening agent, an anti-inflammatory agent, an immunostimulant, an external preparation for skin, a functional oral composition containing a plant of Woodwardia or an extract thereof. Related to things.

従来、皮膚の乾燥を防ぎ、皮膚にうるおいを与える保湿成分を提供するために、様々な有効成分の配合検討がなされてきた。また、加齢、疾患、ストレス、紫外線などによるシワ、シミ、皮膚の弾力低下といった皮膚症状の要因として、乾燥、細胞機能低下、紫外線によるメラニン産生や色素沈着、真皮マトリックス成分の減少や変性、紫外線などによる細胞の酸化障害などが挙げられる。このような皮膚症状を防止・改善するために、様々な有効成分の検索および配合検討がなされてきた。特に天然由来成分は、様々な薬理作用や美容効果を有することが知られ、これまでにも数多くの植物や菌類などの抽出物の皮膚外用剤、経口組成物への応用が検討されてきた。   Conventionally, in order to provide a moisturizing ingredient that prevents the skin from drying and moisturizes the skin, various active ingredients have been studied. Moreover, as factors of skin symptoms such as aging, diseases, stress, wrinkles due to ultraviolet rays, blemishes, reduced skin elasticity, dryness, cellular function decline, melanin production and pigmentation due to ultraviolet rays, decrease and degeneration of dermal matrix components, ultraviolet rays Oxidative damage of cells due to the above. In order to prevent and ameliorate such skin symptoms, various active ingredients have been searched and formulated. In particular, naturally-derived components are known to have various pharmacological and cosmetic effects, and the application of extracts such as plants and fungi to skin external preparations and oral compositions has been studied so far.

例えば、皮膚の保湿効果と安全性に優れた保湿剤としてハリブキ属植物の抽出物(特許文献1参照)、皮膚の老化防止、改善作用を有する皮膚外用剤を得るために、真皮線維芽細胞の賦活あるいは増殖促進作用を有する成分としてポンカンのエッセンス(特許文献2参照)、ツリガネニンジン属植物の抽出物(特許文献3参照)、クロレラ抽出物(特許文献4参照)、ビワ抽出物(特許文献5参照)等が開示されている。抗酸化剤としてはサルオガセ科サルオガセ属植物の抽出物(特許文献6参照)等が、生体内の脂肪蓄積を抑制する成分としては、シッポゴケ科植物の抽出物(特許文献7参照)等が、美白剤としては、白鶴霊芝の抽出物(特許文献8参照)等が、抗炎症作用を有する植物エキスとして、蘇葉、カカオ及び茴香の乾燥物又はその熱水抽出エキス(特許文献9参照)、カンナ科植物の溶媒抽出物(特許文献10参照)等が、免疫賦活剤としては、ニラの種子及び/又はその抽出物(特許文献11参照)等が、それぞれすでに知られている。   For example, in order to obtain an extract of a plant belonging to the genus Halibut (see Patent Document 1) as a moisturizing agent excellent in skin moisturizing effect and safety, and to obtain a skin external preparation having an anti-aging and improving action on the skin, The essence of Ponkan as a component having an activation or growth promoting action (see Patent Document 2), an extract of plants belonging to the genus Genus ginseng (see Patent Document 3), a chlorella extract (see Patent Document 4), and a loquat extract (see Patent Document 5) ) Etc. are disclosed. As an antioxidant, an extract of a plant belonging to the genus Sarogaceae (see Patent Document 6) or the like is used, and as an ingredient that suppresses fat accumulation in the living body, an extract of a plant belonging to the family Schipokeaceae (see Patent Document 7) or the like is whitened. As an agent, an extract of white crane reishi (see Patent Document 8) and the like, a plant extract having an anti-inflammatory action, a dried product of soba, cacao and musk or a hot water extract thereof (see Patent Document 9), A solvent extract of Cannaceae plants (see Patent Document 10) and the like, and leek seeds and / or extracts thereof (see Patent Document 11) and the like are already known as immunostimulants.

特開2007−77072号公報JP 2007-77072 A 特開2001−131045号公報JP 2001-131045 A 特開2000−178198号公報JP 2000-178198 A 特開平11−335293号公報JP 11-335293 A 特公平5−17206号公報Japanese Patent Publication No. 5-17206 特開平10−182413号公報Japanese Patent Laid-Open No. 10-182413 特開2005−60345号公報JP 2005-60345 A 特開2003−89630号公報JP 2003-89630 A 特開2003−201246号公報JP 2003-201246 A 特開平4−270224号公報JP-A-4-270224 特開2008−31122公報JP 2008-31122 A

このように、これまでに様々な天然由来成分が応用されている。しかし、天然由来成分の中には、未だその効果が知られていないものも数多く存在し、優れた保湿効果、抗老化効果、抗酸化効果、痩身効果、美白効果、抗炎症効果、免疫賦活効果を有する有効成分の開発が期待されていた。   Thus, various naturally-derived components have been applied so far. However, there are many naturally derived ingredients whose effects are not yet known. Excellent moisturizing effect, anti-aging effect, antioxidant effect, slimming effect, whitening effect, anti-inflammatory effect, immunostimulatory effect The development of an active ingredient having a potential has been expected.

本発明者らは、天然由来の種々の成分について検討を行った結果、従来はその効果が知られていなかったコモチシダ属植物またはその抽出物に優れた保湿効果、抗老化効果、抗酸化効果、痩身効果、美白効果、抗炎症効果、免疫賦活効果が存在することを見出し、さらに検討を重ねて本発明を完成させるに至った。   As a result of studying various components derived from nature, the present inventors, as a result, have excellent moisturizing effect, anti-aging effect, anti-oxidation effect, etc. The present inventors have found that a slimming effect, a whitening effect, an anti-inflammatory effect, and an immunostimulatory effect exist, and have further studied and completed the present invention.

すなわち本発明は、コモチシダ属植物より選ばれる少なくとも1種の植物またはその抽出物を含有する保湿剤、抗老化剤、抗酸化剤、痩身剤、美白剤、抗炎症剤、免疫賦活剤、皮膚外用剤、機能性経口組成物に関する。   That is, the present invention relates to a moisturizer, an anti-aging agent, an antioxidant, a slimming agent, a whitening agent, an anti-inflammatory agent, an immunostimulant, and an external preparation for skin containing at least one plant selected from the plant belonging to the genus Comotida The present invention relates to an agent and a functional oral composition.

本発明によれば、コモチシダ属植物より選ばれる1種または2種以上の植物またはその抽出物を配合することにより、優れた効果を有する保湿剤、抗老化剤、抗酸化剤、痩身剤、美白剤、抗炎症剤、免疫賦活剤、皮膚外用剤、機能性経口組成物を提供することができる。   According to the present invention, a moisturizer, an anti-aging agent, an antioxidant, a slimming agent, a whitening agent having excellent effects can be obtained by blending one or two or more kinds of plants selected from the plant belonging to the genus Cocomitida or an extract thereof. An agent, an anti-inflammatory agent, an immunostimulant, an external preparation for skin, and a functional oral composition can be provided.

本発明で用いるコモチシダ属植物は、シシガシラ科(Blechnaceae)に属する多年草で、宮城県以南・富山県以西の本州、四国、九州に分布し、ヨーロッパやアメリカでは観賞用にされている。コモチシダ属には、アイオオカグマ(Woodwardia × intermedia H.Christ)、アイコモチシダ(Woodwardia orientalis Sw. × Woodwardia orientalis Sw. var. formosana Rosenst.)、イズコモチシダ(Woodwardia × izuensis Sa.Kurata)、オオカグマ(Woodwardia japonica (L.f.) J.Sm.)、オオギミシダ(Woodwardia harlandii Hook.)、コモチシダ(Woodwardia orientalis Sw.)、ハイコモチシダ(別名:ジョウレンシダ)(Woodwardia unigemmata (Makino) Nakai)、ハチジョウカグマ(別名:タイワンコモチシダ)(Woodwardia orientalis Sw. var. formosana Rosenst.)、トサノオオカグマ(Woodwardia japonica (L. fil.) Sm. var. latisecta Tagawa)、およびホソバオオカグマ(Woodwardia kempii Copel.)が知られている。   The plant belonging to the genus Kochicida used in the present invention is a perennial plant belonging to the family Blencaceae, distributed in Honshu, Shikoku, and Kyushu, south of Miyagi Prefecture and west of Toyama Prefecture, and is ornamental in Europe and the United States. The Komochishida genus Aiookaguma (Woodwardia × intermedia H.Christ), eye Komochishida (Woodwardia orientalis Sw. × Woodwardia orientalis Sw. Var. Formosana Rosenst.), IS Komochishida (Woodwardia × izuensis Sa.Kurata), Ookaguma (Woodwardia japonica ( L. f.) J. Sm.), Woodwardia harlandii Hook. Bearwardia orientalis Sw. Var. Formana Rosenst., Woodwarda japonica (L. fil. EWo wa. .

本発明は、コモチシダ属植物であれば特に限定されないが、本発明の効果の点から適当なものとして、ハチジョウカグマ(別名:タイワンコモチシダ)(Woodwardia orientalis Sw. var. formosana Rosenst.)が挙げられる。   The present invention is not particularly limited as long as it is a plant belonging to the genus Comotidida, but as a suitable one from the viewpoint of the effect of the present invention, there is exemplified bee brown bear (alias: Thaiwan Komotida) (Woodwardia orientalis Sw. Var. Formosa Rosenst.).

これらコモチシダ属植物を使用する際は、その使用部位には特に制限はなく、胞子体、配偶体のいずれの部位を用いても構わないが、簡便に利用するには、胞子体の全草、根、全葉、葉身、葉柄などを用いるとよい。好ましくは、葉身、葉柄などを含む全葉がよい。   When using these plants belonging to the genus Komotichida, there are no particular restrictions on the site of use, and any part of the spore body or gametophyte may be used. Use roots, whole leaves, leaf blades, petiole, etc. Preferably, all leaves including leaf blades, petiole and the like are good.

抽出の際は、植物を生のまま用いてもよいが、抽出効率を考えると、細切、乾燥、粉砕等の処理を行った後に抽出を行うことが好ましい。   In the extraction, the plant may be used as it is, but considering the extraction efficiency, it is preferable to perform the extraction after performing processing such as shredding, drying, and pulverization.

抽出は、任意の抽出溶媒に所定時間浸漬して行うことができる。抽出溶媒は、必要に応じて加熱してもよい。あるいは、超臨界流体や亜臨界流体を用いた抽出方法でも行うことができる。抽出効率を上げるため、撹拌したり、抽出溶媒中でホモジナイズしたりしてもよい。抽出温度としては、5℃程度から抽出溶媒の沸点以下の温度とするのが適切である。抽出時間は、抽出溶媒の種類や抽出温度によっても異なるが、1時間〜14日間程度とするのが適切である。   The extraction can be performed by immersing in an arbitrary extraction solvent for a predetermined time. The extraction solvent may be heated as necessary. Alternatively, extraction can be performed using a supercritical fluid or a subcritical fluid. In order to increase extraction efficiency, stirring or homogenization in an extraction solvent may be performed. The extraction temperature is suitably about 5 ° C. to the boiling point of the extraction solvent. The extraction time varies depending on the type of extraction solvent and the extraction temperature, but is suitably about 1 hour to 14 days.

抽出溶媒としては、水の他、メタノール、エタノール、プロパノール、イソプロパノール等の低級アルコール;1,3−ブチレングリコール、プロピレングリコール、ジプロピレングリコール、グリセリン等の多価アルコール;エチルエーテル、プロピルエーテル等のエーテル類;酢酸ブチル、酢酸エチル等のエステル類;アセトン、エチルメチルケトン等のケトン類などの溶媒を用いることができ、好ましくは、水、エタノールがよい。これらは単独で用いられるほか、任意の2種以上を組み合わせて用いてもよい。生理食塩水、リン酸緩衝液、リン酸緩衝生理食塩水等を用いてもよい。さらに、水や二酸化炭素、エチレン、プロピレン、エタノール、メタノール、アンモニアなどの1種または2種以上の超臨界液体や亜臨界液体を用いてもよく、好ましくは、二酸化炭素がよい。   As an extraction solvent, in addition to water, lower alcohols such as methanol, ethanol, propanol and isopropanol; polyhydric alcohols such as 1,3-butylene glycol, propylene glycol, dipropylene glycol and glycerin; ethers such as ethyl ether and propyl ether Solvents such as esters such as butyl acetate and ethyl acetate; ketones such as acetone and ethyl methyl ketone can be used, and water and ethanol are preferable. These may be used alone or in combination of any two or more. Saline, phosphate buffer, phosphate buffered saline, and the like may be used. Furthermore, one kind or two or more kinds of supercritical liquids and subcritical liquids such as water, carbon dioxide, ethylene, propylene, ethanol, methanol, and ammonia may be used, and carbon dioxide is preferred.

コモチシダ属植物の上記溶媒による抽出物は、そのままでも使用することができるが、一定期間そのまま静置して熟成させて用いてもよいし、濃縮、乾固した物を水や極性溶媒に再度溶解して使用することもできる。あるいは、これらの生理作用を損なわない範囲で、脱色、脱臭、脱塩等の精製処理や、カラムクロマトグラフィー等による分画処理を行った後に用いてもよい。コモチシダ属植物の前記抽出物やその処理物および分画物は、各処理および分画後に凍結乾燥し、用時溶媒に溶解して用いることもできる。また、リポソーム等のベシクルやマイクロカプセル等に内包させて用いることもできる。   Extracts of the above-mentioned solvents of the genus Cocomicida can be used as they are, but they may be left to stand for a certain period of time and matured, or the concentrated and dried solids are dissolved again in water or a polar solvent. Can also be used. Alternatively, it may be used after performing purification treatment such as decolorization, deodorization, and desalting, and fractionation treatment by column chromatography or the like within a range not impairing these physiological functions. The above-mentioned extract of the genus Cocomitida, its treated product and fractionated product can be freeze-dried after each treatment and fractionation and dissolved in a solvent before use. It can also be used by encapsulating in vesicles such as liposomes or microcapsules.

コモチシダ属植物またはその抽出物は、優れた保湿効果、抗老化効果、抗酸化効果、痩身効果、美白効果、抗炎症効果、免疫賦活効果を有し、保湿剤、抗老化剤、抗酸化剤、痩身剤、美白剤、抗炎症剤、免疫賦活剤、皮膚外用剤、機能性経口組成物として利用することができる。   The plant belonging to the genus Comotidida or its extract has excellent moisturizing effect, anti-aging effect, antioxidant effect, slimming effect, whitening effect, anti-inflammatory effect, immunostimulatory effect, moisturizing agent, anti-aging agent, antioxidant agent, It can be used as a slimming agent, whitening agent, anti-inflammatory agent, immunostimulant, skin external preparation, and functional oral composition.

コモチシダ属植物またはその抽出物を有効成分とする保湿剤は、優れたヒト真皮線維芽細胞のヒアルロン酸産生促進作用およびヒト表皮角化細胞のアルギナーゼ活性促進作用を有し、優れた保湿効果を発揮する。   A moisturizing agent containing a plant belonging to the genus Komotichida or its extract as an active ingredient has an excellent hyaluronic acid production promoting action of human dermal fibroblasts and an arginase activity promoting action of human epidermal keratinocytes, and exhibits an excellent moisturizing effect. To do.

コモチシダ属植物またはその抽出物を有効成分とする抗老化剤は、優れたヒト真皮線維芽細胞の賦活作用、ヒト真皮線維芽細胞の細胞賦活作用、ヒト真皮線維芽細胞タイプIのコラーゲン産生促進作用、ヒト真皮線維芽細胞のATP産生促進作用、ヒト表皮角化細胞の賦活作用、およびヒト表皮角化細胞タイプIVのコラーゲン産生促進作用を有し、老化症状の防止・改善に優れた効果を発揮する。   An anti-aging agent comprising a plant belonging to the genus Cocomicida or an extract thereof as an active ingredient is an excellent human dermal fibroblast activation effect, a human dermal fibroblast cell activation effect, and a human dermal fibroblast type I collagen production promoting effect. Has the effect of promoting ATP production of human dermal fibroblasts, activating human epidermal keratinocytes, and promoting collagen production of human epidermal keratinocytes type IV, and is excellent in preventing and improving aging symptoms To do.

コモチシダ属植物またはその抽出物を有効成分とする抗酸化剤は、優れた過酸化脂質耐性、ラジカル消去作用、スーパーオキサイドアニオン消去作用を有し、優れた抗酸化効果を発揮する。   Antioxidants containing Komotichida plants or their extracts as active ingredients have excellent lipid peroxide resistance, radical scavenging action, and superoxide anion scavenging action, and exhibit excellent antioxidant effects.

コモチシダ属植物またはその抽出物を有効成分とする痩身剤は、優れたヒト前駆脂肪細胞の中性脂肪蓄積抑制作用を有し、優れた痩身効果を発揮する。   A slimming agent comprising a plant belonging to the genus Komotichida or an extract thereof as an active ingredient has an excellent action of inhibiting neutral fat accumulation of human preadipocytes and exhibits an excellent slimming effect.

コモチシダ属植物またはその抽出物を有効成分とする美白剤は、優れたヒト表皮メラニン細胞のチロシナーゼ活性阻害作用およびB16マウスメラノーマ細胞メラニン産生抑制作用を有し、色素沈着、シミ、そばかす等を予防・改善して、優れた美白効果を発揮する。   A whitening agent containing a plant belonging to the genus Komotichida or an extract thereof as an active ingredient has an excellent inhibitory effect on tyrosinase activity of human epidermal melanocytes and an inhibitory effect on melanin production of B16 mouse melanoma cells, and prevents pigmentation, spots, freckles, etc. Improve and show excellent whitening effect.

コモチシダ属植物またはその抽出物を有効成分とする炎症剤は、優れたヒアルロニダーゼ阻害作用を有し、優れた抗炎症効果を発揮する。   An inflammatory agent comprising a Cocomitida plant or an extract thereof as an active ingredient has an excellent hyaluronidase inhibitory action and exhibits an excellent anti-inflammatory effect.

コモチシダ属植物またはその抽出物を有効成分とする免疫賦活剤は、ヒト急性単球白血病細胞株を用いた細胞賦活作用を有し、優れた免疫賦活効果を発揮する。   An immunostimulant comprising a Comotidida plant or an extract thereof as an active ingredient has a cell activation effect using a human acute monocyte leukemia cell line and exhibits an excellent immunostimulatory effect.

コモチシダ属植物またはその抽出物を含有する皮膚外用剤は、優れた保湿効果、抗老化効果、抗酸化効果、痩身効果、美白効果、抗炎症効果、免疫賦活効果などを発揮する。   An external preparation for skin containing a plant belonging to the genus Komotichida or an extract thereof exhibits an excellent moisturizing effect, anti-aging effect, antioxidant effect, slimming effect, whitening effect, anti-inflammatory effect, immunostimulatory effect, and the like.

コモチシダ属植物またはその抽出物を含有する機能性経口組成物は、優れた保湿効果、抗老化効果、抗酸化効果、痩身効果、美白効果、抗炎症効果、免疫賦活効果などを発揮する。   A functional oral composition containing a plant belonging to the genus Commonis or its extract exhibits an excellent moisturizing effect, anti-aging effect, antioxidant effect, slimming effect, whitening effect, anti-inflammatory effect, immunostimulatory effect, and the like.

これらの各剤は、コモチシダ属植物またはその抽出物を有効成分として含む限り、その形態およびその他成分の配合の有無等については、何ら制限されない。形態については、液状、ペースト状、ゲル状、固体状または粉末状等の任意の形態を、その用途等に応じて選択でき、その形態とするために必要なビヒクル(賦形剤)、溶剤、またはその他の一般的な添加剤(酸化防止剤、着色剤または分散剤等)を任意に含むことができる。   Each of these agents is not limited at all in terms of its form and presence / absence of other components as long as it contains a Cocomitida plant or an extract thereof as an active ingredient. As for the form, any form such as liquid, paste, gel, solid or powder can be selected according to its use and the like, vehicle (excipient), solvent, Or other general additives (an antioxidant, a coloring agent, a dispersing agent etc.) can be included arbitrarily.

ここで皮膚外用剤とは、化粧料、医薬部外品または外用医薬品等の皮膚または毛髪に外用される全ての外用組成物を意味している。機能性経口組成物についても、医薬品、食品または飲料等の種類を問わず、経口により摂取される全ての組成物を意味する。   Here, the external preparation for skin means all external compositions for external use on the skin or hair, such as cosmetics, quasi-drugs or external pharmaceuticals. The functional oral composition also means all compositions that are taken orally, regardless of the type of medicine, food, beverage or the like.

皮膚外用剤の剤型は任意であり、例えば、ローション等の可溶化系、カラミンローション等の分散系、またはクリームや乳液等の乳化系として提供することができる。さらに、噴射剤と共に充填するエアゾール形態、軟膏剤またはパップ剤等の種々の剤型で提供することもできる。   The dosage form of the external preparation for skin is arbitrary, and can be provided, for example, as a solubilization system such as lotion, a dispersion system such as calamine lotion, or an emulsification system such as cream or emulsion. Furthermore, it can also be provided in various dosage forms such as aerosol form, ointment or poultice filled with propellant.

具体的には、乳液、クリーム、ローション、化粧水、パック、美容液、洗浄料またはメイクアップ化粧料等の各種化粧料;液剤、軟膏、粉末、顆粒、エアゾール剤、貼付剤またはパップ剤等の様々な形態の化粧料、医薬部外品または外用医薬品などが例示できる。   Specifically, various cosmetics such as emulsions, creams, lotions, lotions, packs, cosmetic liquids, cleaning agents or makeup cosmetics; liquids, ointments, powders, granules, aerosols, patches or poultices Various forms of cosmetics, quasi-drugs, or external medicines can be exemplified.

機能性経口組成物の形態も任意であり、特に限定されることはない。具体的には、飲料を含む一般食品;錠剤、カプセル剤、顆粒剤、散剤等の健康食品(サプリメント)または機能性食品;錠剤、カプセル剤、顆粒剤、散剤、シロップ剤またはエキス等の経口医薬品などが例示できる。   The form of the functional oral composition is also arbitrary and is not particularly limited. Specifically, general foods including beverages; health foods (supplements) such as tablets, capsules, granules, powders or functional foods; oral drugs such as tablets, capsules, granules, powders, syrups or extracts Etc. can be exemplified.

皮膚外用剤または機能性経口組成物には、コモチシダ属植物またはその抽出物の他に、その用途と必要に応じて、医薬品、医薬部外品、皮膚化粧料、毛髪用化粧料および洗浄料等に通常配合される任意の成分、例えば水、油性成分、保湿剤、粉体、色素、乳化剤、可溶化剤、ゲル化剤、洗浄剤、紫外線吸収剤、抗炎症剤、増粘剤、pH調整剤、キレート剤、薬剤(薬効成分)、香料、樹脂、防菌防かび剤、抗酸化剤、またはアルコール類等を適宜配合することができる。さらに、本発明の効果を損なわない範囲において、他の保湿剤、抗老化剤、抗酸化剤、痩身剤、美白剤、抗炎症剤、免疫賦活剤あるいはコモチシダ属植物以外の植物またはその抽出物との併用も可能である。   For topical skin preparations or functional oral compositions, in addition to the plants belonging to the genus Cocomicidae or extracts thereof, pharmaceuticals, quasi-drugs, skin cosmetics, cosmetics for hair, cleaning agents, etc. Optional ingredients usually formulated in water, such as water, oily ingredients, moisturizers, powders, pigments, emulsifiers, solubilizers, gelling agents, cleaning agents, UV absorbers, anti-inflammatory agents, thickeners, pH adjustment Agents, chelating agents, drugs (medicinal ingredients), fragrances, resins, fungicides, fungicides, antioxidants, alcohols, and the like can be appropriately blended. Furthermore, within the range that does not impair the effects of the present invention, other moisturizers, anti-aging agents, antioxidants, slimming agents, whitening agents, anti-inflammatory agents, immunostimulants or plants other than the genus Cocomitida or extracts thereof Can be used in combination.

飲食品等の経口組成物の場合も、経口用として通常用いられる各種成分との組み合わせにおいて、特に限定されるものではない。   Also in the case of oral compositions such as foods and drinks, there is no particular limitation in combination with various components that are usually used for oral use.

コモチシダ属植物またはその抽出物の皮膚外用剤または機能性経口組成物への配合量は、種類や目的等によって調整することができるが、効果や安定性などの点から、全量に対して固形分換算で、好ましくは0.0001〜10.0質量%であり、より好ましくは0.001〜5.0質量%であり、さらに好ましくは0.01〜5質量%であり、一層好ましくは0.1〜5質量%である。   The amount of the common genus plant or its extract to the topical skin preparation or functional oral composition can be adjusted depending on the type, purpose, etc. In terms of conversion, it is preferably 0.0001 to 10.0% by mass, more preferably 0.001 to 5.0% by mass, still more preferably 0.01 to 5% by mass, and still more preferably 0.00. 1 to 5% by mass.

以下にコモチシダ属植物抽出物の調製例、保湿効果、抗老化効果、抗酸化効果、痩身効果、美白効果、抗炎症効果および免疫賦活効果を評価するための試験方法、皮膚外用剤または機能性食品としての処方例についてさらに詳細に説明するが、本発明の技術的範囲はこれらによってなんら限定されるものではない。   Examples of preparations of the plant extract of the genus Komotichida, test methods for evaluating moisturizing effect, anti-aging effect, antioxidant effect, slimming effect, whitening effect, anti-inflammatory effect and immunostimulatory effect, topical skin preparation or functional food However, the technical scope of the present invention is not limited in any way by these.

[抽出物1]
ハチジョウカグマの新葉の乾燥粉砕物100gに、50質量%エタノール水溶液を2.0Kg加え、撹拌しながら室温にて2時間抽出した。抽出液をろ過して回収し、減圧濃縮後、凍結乾燥を行い、抽出物1を得た。
[Extract 1]
To 100 g of dry ground pulverized product of honey bee bear, 2.0 kg of 50 mass% ethanol aqueous solution was added and extracted at room temperature for 2 hours with stirring. The extract was collected by filtration, concentrated under reduced pressure, and lyophilized to obtain extract 1.

[抽出物2]
ハチジョウカグマの古葉の乾燥粉砕物100gに、50質量%エタノール水溶液を2.0Kg加え、撹拌しながら室温にて2時間抽出した。抽出液をろ過して回収し、減圧濃縮後、凍結乾燥を行い、抽出物2を得た。
[Extract 2]
To 100 g of dry ground pulverized leaves of bee bear, 2.0 kg of 50 mass% ethanol aqueous solution was added and extracted at room temperature for 2 hours with stirring. The extract was collected by filtration, concentrated under reduced pressure, and lyophilized to obtain extract 2.

[抽出物3]
ハチジョウカグマの新葉の乾燥粉砕物5gに精製水を100g加え、120℃で20分間抽出した。抽出液をろ過して回収し、凍結乾燥を行い、抽出物3を得た。
[Extract 3]
100 g of purified water was added to 5 g of dry ground pulverized product of bee brown bear and extracted at 120 ° C. for 20 minutes. The extract was collected by filtration and lyophilized to obtain Extract 3.

[抽出物4]
ハチジョウカグマの古葉の乾燥粉砕物5gに精製水を100g加え、120℃で20分間抽出した。抽出液をろ過して回収し、凍結乾燥を行い、抽出物4を得た。
[Extract 4]
100 g of purified water was added to 5 g of dried ground pulverized leaves of bee bears and extracted at 120 ° C. for 20 minutes. The extract was collected by filtration and freeze-dried to obtain extract 4.

[抽出物5]
ハチジョウカグマの新葉を乾燥させて粉砕し、セルに充填する。2時間、25Mpa、40℃、5mL/分の条件で液化二酸化炭素をセルに送液し抽出物5を得た。
[Extract 5]
The new leaves of bee bear bear are dried, crushed and filled into cells. Extract 2 was obtained by feeding liquefied carbon dioxide into the cell under the conditions of 25 Mpa, 40 ° C., and 5 mL / min for 2 hours.

[抽出物6]
ハチジョウカグマの古葉を乾燥させて粉砕し、セルに充填する。2時間、25Mpa、40℃、5mL/分の条件で液化二酸化炭素をセルに送液し抽出物6を得た。
[Extract 6]
The old leaves of bee bears are dried, crushed and filled into cells. Extract 2 was obtained by feeding liquefied carbon dioxide into the cell under the conditions of 25 Mpa, 40 ° C. and 5 mL / min for 2 hours.

ここで言う、新葉とは赤みのある葉を用い、古葉とは緑色の葉を用いた。上記抽出物を用いて、各効果の評価を行った。なお各評価結果に記載した*および**は、t検定における有意確率P値に対し、有意確率5%未満(P<0.05)を*で、有意確率1%未満(P<0.01)を**でそれぞれ表したものである。   The new leaves used here are red leaves, and the old leaves are green leaves. Each effect was evaluated using the said extract. Note that * and ** described in each evaluation result indicate that the significance probability P value in the t-test is less than 5% (P <0.05), and less than 1% significance (P <0.01). ) Is represented by **.

<保湿効果(ヒト真皮線維芽細胞ヒアルロン酸産生促進作用の評価)>
正常ヒト真皮繊維芽細胞を1ウェル当り2.0×10個となるように96ウェルマイクロプレートに播種した。播種培地には5質量%のウシ胎児血清(FBS)を添加したダルベッコ改変イーグル培地(DMEM)を用いた。24時間後、0.5質量%FBS添加DMEM培地にて表1に示す各濃度となるように抽出物3を添加したサンプル培養液に交換し、さらに3日間培養した。培養上清中に分泌されたヒアルロン酸の定量には、プロテオグリカンを用いた間接ELISA法を用い、最後は標識されたペルオキシダーゼに対し2,2’−アジノビス(3−エチルベンゾチアゾリン−6−スルホン酸)ジアンモニウム塩(ABTS)および過酸化水素を添加し反応させた後、マイクロプレートリーダーにて405nmの吸光度を測定した。PIERCE社製BCAプロテインアッセイキットにて各ウェルのタンパク量を測定し、単位タンパク量当りのヒアルロン酸産生量を求めた。
評価結果を試料無添加のコントロールにおける単位タンパク量当りのヒアルロン酸産生量を100とした相対値にて表1に示す。
<Moisturizing effect (Evaluation of human dermal fibroblast hyaluronic acid production promoting effect)>
Normal human dermal fibroblasts were seeded in a 96-well microplate at 2.0 × 10 4 cells per well. Dulbecco's modified Eagle medium (DMEM) supplemented with 5% by weight fetal bovine serum (FBS) was used as the seeding medium. After 24 hours, the culture medium was replaced with a sample culture solution to which the extract 3 was added so as to have each concentration shown in Table 1 in a DMEM medium supplemented with 0.5% by mass FBS, and further cultured for 3 days. For the quantification of hyaluronic acid secreted into the culture supernatant, an indirect ELISA method using proteoglycan was used, and finally 2,2′-azinobis (3-ethylbenzothiazoline-6-sulfonic acid against labeled peroxidase. ) After diammonium salt (ABTS) and hydrogen peroxide were added and reacted, the absorbance at 405 nm was measured with a microplate reader. The amount of protein in each well was measured with a BCA protein assay kit manufactured by PIERCE, and the amount of hyaluronic acid produced per unit protein amount was determined.
The evaluation results are shown in Table 1 as relative values with the amount of hyaluronic acid produced per unit protein in the control with no sample added as 100.

Figure 0005388555
Figure 0005388555

表1の結果から明らかなように、ハチジョウカグマ(新葉)熱水抽出物(抽出物3)は有意な保湿効果が認められた。 As is clear from the results in Table 1, the bee brown bear (new leaf) hot water extract (Extract 3) showed a significant moisturizing effect.

<保湿効果(ヒト表皮角化細胞アルギナーゼ活性促進作用の評価)>
ヒト表皮角化細胞HaCaTを1ウェル当り2.0×10個となるように96ウェルマイクロプレートに播種した。播種培地には5質量%のウシ胎児血清(FBS)を添加したダルベッコ改変イーグル培地(DMEM)を用いた。24時間後1.2mM CaClを含む5質量%FBS添加DMEM培地(分化誘導培地)にて表2に示す各濃度に抽出物5を添加したサンプル培養液に交換し、さらに9日間培養した。培地交換は3日に1回のペースで行った。培養上清中に分泌された尿素の定量には、尿素窒素 B−テストワコー(和光純薬)を用いた。アルギナーゼはアルギニンを加水分解し、オルニチン、尿素を生成する。尿素はウレアーゼによってアンモニアに分解され、アンモニアはペンタシアノニトロシル鉄(III)酸ナトリウム二水和物(ニトロプルシッドナトリウム)存在下でサリチル酸、次亜塩素酸と反応し、インドフェノールが生成する。アルカリ性条件下でインドフェノールに由来する570nmの吸光度を測定し、尿素濃度を求め、アルギナーゼ活性の定量を行った。PIERCE社製BCAプロテインアッセイキットにて各ウェルのタンパク量を測定し、単位タンパク量当りのアルギナーゼ活性を求めた。
評価結果を試料無添加のコントロールにおける単位タンパク量当りのアルギナーゼ活性を100とした時の相対値にて表2に示す。
<Moisturizing effect (Evaluation of human epidermal keratinocyte arginase activity promoting effect)>
Human epidermal keratinocytes HaCaT were seeded in a 96-well microplate so as to be 2.0 × 10 4 cells per well. Dulbecco's modified Eagle medium (DMEM) supplemented with 5% by weight fetal bovine serum (FBS) was used as the seeding medium. After 24 hours, the sample culture medium was replaced with a 5% FBS-added DMEM medium (differentiation induction medium) containing 1.2 mM CaCl 2 with each extract 5 added to each concentration shown in Table 2, and further cultured for 9 days. The medium was exchanged once every 3 days. Urea nitrogen B-Test Wako (Wako Pure Chemical Industries) was used for quantification of urea secreted into the culture supernatant. Arginase hydrolyzes arginine to produce ornithine and urea. Urea is decomposed into ammonia by urease, and ammonia reacts with salicylic acid and hypochlorous acid in the presence of sodium pentacyanonitrosyl iron (III) dihydrate (sodium nitroprusside) to produce indophenol. Absorbance at 570 nm derived from indophenol was measured under alkaline conditions, the urea concentration was determined, and arginase activity was quantified. The protein amount in each well was measured with a BCA protein assay kit manufactured by PIERCE, and the arginase activity per unit protein amount was determined.
The evaluation results are shown in Table 2 as relative values when the arginase activity per unit protein amount in the control with no sample added is defined as 100.

Figure 0005388555
Figure 0005388555

表2の結果から明らかなように、ハチジョウカグマ(古葉)超臨界抽出物(抽出物5)は有意な保湿効果が認められた。 As is clear from the results in Table 2, the bee brown bear (old leaf) supercritical extract (Extract 5) showed a significant moisturizing effect.

上述のとおり、ハチジョウカグマ抽出物は、ヒアルロン酸産生促進作用およびアルギナーゼ活性促進作用を有し、優れた保湿効果を発揮する。 As described above, the bee brown bear extract has a hyaluronic acid production promoting action and an arginase activity promoting action, and exhibits an excellent moisturizing effect.

<抗老化効果(ヒト真皮線維芽細胞賦活作用の評価)>
クラボウ社(倉敷紡績株式会社)製正常ヒト真皮線維芽細胞を、1ウェル当たり2.0×10個となるように96穴マイクロプレート播種した。播種培地には、ダルベッコ改変イーグル培地(DMEM)に1質量%のウシ胎児血清(FBS)を添加したものを用いた。24時間培養後、表3に示す各濃度となるように抽出物1を添加した1質量%FBS添加DMEM培地に交換し、さらに48時間培養した。上清を除いた後、3−(4,5−ジメチル−2−チアゾリル)−2,5−ジフェニルテトラゾリウムブロミド(MTT)を400μg/mL含有する培地に交換して約2時間培養した。その後、テトラゾリウム環の開環により生じるフォルマザンを2−プロパノールにて抽出し、マイクロプレートリーダーにて550nmの吸光度を測定した。同時に、濁度として650nmにおける吸光度を測定し、両測定値の差により細胞賦活作用を評価した。評価では、試料を含む培地の他に、コントロールとして1質量%FBS添加DMEM培地を用いた。
評価結果を、コントロールにおける細胞賦活作用を100とした場合の相対値として表3に示す。
<Anti-aging effect (evaluation of human dermal fibroblast activation)>
Normal human dermal fibroblasts manufactured by Kurabo Industries Co., Ltd. (Kurashiki Boseki Co., Ltd.) were seeded in a 96-well microplate so as to be 2.0 × 10 4 cells per well. As the seeding medium, Dulbecco's modified Eagle medium (DMEM) to which 1% by mass of fetal bovine serum (FBS) was added was used. After culturing for 24 hours, the medium was exchanged with 1% by mass FBS-added DMEM medium to which extract 1 was added so as to have each concentration shown in Table 3, and further cultured for 48 hours. After removing the supernatant, the medium was replaced with a medium containing 400 μg / mL of 3- (4,5-dimethyl-2-thiazolyl) -2,5-diphenyltetrazolium bromide (MTT) and cultured for about 2 hours. Thereafter, formazan produced by the opening of the tetrazolium ring was extracted with 2-propanol, and the absorbance at 550 nm was measured with a microplate reader. At the same time, the absorbance at 650 nm was measured as turbidity, and the cell activation effect was evaluated by the difference between the two measured values. In the evaluation, in addition to the medium containing the sample, 1% by mass FBS-added DMEM medium was used as a control.
The evaluation results are shown in Table 3 as relative values when the cell activation effect in the control is 100.

Figure 0005388555
Figure 0005388555

表3の結果から明らかなように、ハチジョウカグマ(新葉)50%エタノール抽出物(抽出物1)を添加した培地では有意な細胞賦活効果が認められた。 As is clear from the results in Table 3, a significant cell activation effect was observed in the medium supplemented with 50% ethanol extract (extract 1) of bee brown bear (new leaf).

<抗老化効果(ヒト真皮繊維芽細胞タイプIコラーゲン産生促進作用の評価)>
正常ヒト真皮繊維芽細胞を1ウェル当り2.0×10個となるように96ウェルマイクロプレートに播種した。播種培地には5質量%のウシ胎児血清(FBS)を添加したダルベッコ改変イーグル培地(DMEM)を用いた。24時間後、0.5質量%FBS添加DMEM培地にて表4に示す各濃度となるように抽出物1を添加した培養液に交換し、さらに24時間培養した。培養上清中に分泌されたタイプIコラーゲンの定量にはELISA法を用い、最後は標識されたペルオキシダーゼに対し2,2’−アジノビス(3−エチルベンゾチアゾリン−6−スルホン酸)ジアンモニウム塩(ABTS)及び過酸化水素を添加し反応させた後、405nmの吸光度を測定した。PIERCE社製BCAプロテインアッセイキットにて各ウェルのタンパク量を測定し、単位タンパク量当りのタイプIコラーゲン産生量を求めた。
評価結果を試料無添加のコントロールにおける単位タンパク量当りのタイプIコラーゲン産生量を100とした時の相対値にて表4に示す。
<Anti-aging effect (Evaluation of human dermal fibroblast type I collagen production promoting effect)>
Normal human dermal fibroblasts were seeded in a 96-well microplate at 2.0 × 10 4 cells per well. Dulbecco's modified Eagle medium (DMEM) supplemented with 5% by weight fetal bovine serum (FBS) was used as the seeding medium. After 24 hours, the medium was replaced with a culture solution to which the extract 1 was added so that each concentration shown in Table 4 was obtained in a DMEM medium supplemented with 0.5% by mass FBS, and further cultured for 24 hours. The ELISA method was used for the quantification of type I collagen secreted into the culture supernatant. Finally, 2,2′-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt ( ABTS) and hydrogen peroxide were added and reacted, and then the absorbance at 405 nm was measured. The amount of protein in each well was measured with a BCA protein assay kit manufactured by PIERCE, and the amount of type I collagen produced per unit protein amount was determined.
The evaluation results are shown in Table 4 as relative values when the type I collagen production amount per unit protein amount in the control with no sample added is defined as 100.

Figure 0005388555
Figure 0005388555

表4の結果から明らかなように、ハチジョウカグマ(新葉)50%エタノール抽出物(抽出物1)は有意なコラーゲン産生促進効果が認められた。   As is clear from the results in Table 4, the bee brown bear (new leaf) 50% ethanol extract (Extract 1) showed a significant collagen production promoting effect.

<抗老化効果(ヒト真皮線維芽細胞ATP産生促進作用の評価)>
正常ヒト真皮線維芽細胞を1ウェル当り4.0×10個となるように48ウェルマイクロプレートに播種した。播種培地には1質量%のウシ胎児血清(FBS)を添加したダルベッコ改変イーグル培地(DMEM)を用いた。24時間後、1%FBS添加DMEMによって表5に示す各濃度になるように抽出物2を添加した培養液に交換し、さらに24時間培養した。細胞上清を除去し洗浄し、細胞を超音波処理して細胞中のATPを溶出した。その際に細胞内にあるATP分解酵素の溶出を防ぐため、ATP分解酵素阻害剤(Cellstein Hoechst33342)を添加した。ATPの定量にはMolecular Probes社製 ATPデタミネーションキットを使用した。細胞溶解液を試験管に分注し、ルシフェラーゼおよびルシフェリン試薬を添加し、化学発光を測定した。
評価結果を試料無添加のコントロールにおけるATP産生能を100とした相対値にて表5に示す。
<Anti-aging effect (Evaluation of human dermal fibroblast ATP production promoting action)>
Normal human dermal fibroblasts were seeded in a 48-well microplate at 4.0 × 10 4 per well. Dulbecco's modified Eagle medium (DMEM) supplemented with 1% by weight fetal bovine serum (FBS) was used as the seeding medium. After 24 hours, the medium was replaced with a culture solution to which the extract 2 was added so as to have each concentration shown in Table 5 with 1% FBS-added DMEM, and further cultured for 24 hours. The cell supernatant was removed and washed, and the cells were sonicated to elute the ATP in the cells. At that time, an ATP-degrading enzyme inhibitor (Cellstein Hoechst 33342) was added to prevent elution of ATP-degrading enzyme in the cells. ATP determination kit manufactured by Molecular Probes was used for quantification of ATP. The cell lysate was dispensed into a test tube, luciferase and a luciferin reagent were added, and chemiluminescence was measured.
The evaluation results are shown in Table 5 as relative values with the ATP producing ability in the control with no sample added as 100.

Figure 0005388555
Figure 0005388555

表5の結果から明らかなように、ハチジョウカグマ(古葉)50%エタノール抽出物(抽出物2)は有意なATP産生促進効果が認められた。   As is clear from the results in Table 5, the bee brown bear (old leaf) 50% ethanol extract (extract 2) showed a significant ATP production promoting effect.

<抗老化効果(ヒト表皮角化細胞賦活作用の評価)>
ヒト表皮角化細胞HaCaTを1ウェル当り2.0×10個となるように96ウェルマイクロプレートに播種した。播種培地には5質量%のウシ胎児血清(FBS)を添加したダルベッコ改変イーグル培地(DMEM)を用いた。24時間後、5質量%FBS添加DMEM培地にて表6に示す各濃度に抽出物4を添加した培養液に交換し、さらに24時間培養した。次に100μg/mLとなるよう培地にて調整したMTT試薬を、上清を除いた細胞に添加し、約2時間培養した。最後に2−プロパノールにて生じたフォルマザンを抽出し、550nmの吸光度を測定した。同時に濁度として650nmの吸光度を測定し、両測定値の差を用いて細胞賦活作用を評価した。
評価結果を試料無添加のコントロールにおける細胞賦活作用を100とした時の相対値にて表6に示す。
<Anti-aging effect (evaluation of human epidermal keratinocyte activation)>
Human epidermal keratinocytes HaCaT were seeded in a 96-well microplate so as to be 2.0 × 10 4 cells per well. Dulbecco's modified Eagle medium (DMEM) supplemented with 5% by weight fetal bovine serum (FBS) was used as the seeding medium. After 24 hours, the medium was replaced with a culture solution in which the extract 4 was added to each concentration shown in Table 6 in a 5% by mass FBS-added DMEM medium, and further cultured for 24 hours. Next, the MTT reagent adjusted with the culture medium so that it might be set to 100 microgram / mL was added to the cell except the supernatant, and it culture | cultivated for about 2 hours. Finally, formazan produced in 2-propanol was extracted and the absorbance at 550 nm was measured. At the same time, the absorbance at 650 nm was measured as turbidity, and the cell activation effect was evaluated using the difference between the two measured values.
The evaluation results are shown in Table 6 as relative values when the cell activation effect in the control with no sample added is taken as 100.

Figure 0005388555
Figure 0005388555

表6の結果から明らかなように、ハチジョウカグマ(古葉)熱水抽出物(抽出物4)は有意な細胞賦活効果が認められた。   As is clear from the results in Table 6, the bee brown bear (old leaf) hot water extract (extract 4) showed a significant cell activation effect.

<抗老化効果(ヒト表皮角化細胞タイプIVコラーゲン産生促進作用の評価)>
ヒト表皮角化細胞HaCaTを1ウェル当り2.0×10個となるように96ウェルマイクロプレートに播種した。播種培地には5質量%のウシ胎児血清(FBS)を添加したダルベッコ改変イーグル培地(DMEM)を用いた。24時間後、0.5質量%FBS添加DMEM培地にて表7に示す各濃度に抽出物1を添加した培養液に交換し、さらに5日間培養した。培養上清中に分泌されたタイプIVコラーゲンの定量には、タイプIVコラーゲンに対するモノクローナル抗体(認識部位:α2鎖)及びビオチン化ポリクローナル抗体を用いたサンドイッチELISA法を用い、最後はアビジン化ホースラディッシュペルオキシダーゼに対し3,3’,5,5’−テトラメチルベンジジンを添加し反応させた後、650nmの吸光度を測定した。PIERCE社製BCAプロテインアッセイキットにて各ウェルのタンパク量を測定し、単位タンパク量当りのIV型コラーゲン産生量を求めた。
評価結果を試料無添加のコントロールにおける単位タンパク量当りのタイプIVコラーゲン産生量を100とした時の相対値にて表7に示す。
<Anti-aging effect (Evaluation of human epidermal keratinocyte type IV collagen production promoting action)>
Human epidermal keratinocytes HaCaT were seeded in a 96-well microplate so as to be 2.0 × 10 4 cells per well. Dulbecco's modified Eagle medium (DMEM) supplemented with 5% by weight fetal bovine serum (FBS) was used as the seeding medium. After 24 hours, the culture medium was replaced with a culture medium in which the extract 1 was added to each concentration shown in Table 7 in a DMEM medium supplemented with 0.5% by mass FBS, and further cultured for 5 days. For the quantification of type IV collagen secreted into the culture supernatant, a sandwich ELISA method using a monoclonal antibody against type IV collagen (recognition site: α2 chain) and a biotinylated polyclonal antibody was used. Finally, avidinized horseradish peroxidase was used. 3,3 ′, 5,5′-tetramethylbenzidine was added and reacted, and then the absorbance at 650 nm was measured. The amount of protein in each well was measured with a BCA protein assay kit manufactured by PIERCE, and the amount of type IV collagen produced per unit protein was determined.
The evaluation results are shown in Table 7 as relative values when the type IV collagen production amount per unit protein amount in the control with no sample added is defined as 100.

Figure 0005388555
Figure 0005388555

表7の結果から明らかなように、ハチジョウカグマ(新葉)50%エタノール抽出物(抽出物1)は有意なコラーゲン産生促進効果が認められた。   As is clear from the results in Table 7, the bee brown bear (new leaf) 50% ethanol extract (Extract 1) showed a significant collagen production promoting effect.

上述のとおり、ハチジョウカグマ抽出物は、細胞賦活作用、コラーゲン産生促進作用、およびATP産生促進作用を有し、優れた抗老化効果を発揮する。   As described above, the bee brown bear extract has a cell activating action, a collagen production promoting action, and an ATP production promoting action, and exhibits an excellent anti-aging effect.

<抗酸化効果(ヒト表皮角化細胞過酸化脂質耐性の評価)>
ヒト表皮角化細胞HaCaTを1ウェル当り2.0×10個となるように96ウェルマイクロプレートに播種した。播種培地には10質量%のウシ胎児血清(FBS)を添加したダルベッコ改変イーグル培地(DMEM)を用いた。24時間後、10%質量FBS添加DMEM培地にて表8に示す各濃度にするように抽出物4を添加した培養液に交換し、さらに24時間培養した。任意濃度のt−ブチルヒドロペルオキシドを添加したHANK’S(+)溶液に交換し、2時間培養した。さらに、150μg/mLニュートラルレッドを含有するPBS(−)に交換し、37℃にて2時間培養した。次に1%酢酸を含む50%エタノール水溶液に交換し、細胞内に取りこまれたニュートラルレッドを抽出し、抽出液の540nmの吸光度を測定した。
評価結果をt−ブチルヒドロペルオキシド無添加のコントロールにおける細胞生存率を100としたときの相対値にて表8に示す。
<Antioxidant effect (Evaluation of resistance to lipid peroxidation of human epidermal keratinocytes)>
Human epidermal keratinocytes HaCaT were seeded in a 96-well microplate so as to be 2.0 × 10 4 cells per well. Dulbecco's modified Eagle medium (DMEM) supplemented with 10% by weight fetal bovine serum (FBS) was used as the seeding medium. After 24 hours, the medium was replaced with a culture solution to which the extract 4 was added so as to have each concentration shown in Table 8 in a DMEM medium supplemented with 10% mass FBS, and further cultured for 24 hours. The solution was replaced with a HANK'S (+) solution to which an arbitrary concentration of t-butyl hydroperoxide was added, and cultured for 2 hours. Furthermore, it replaced | exchanged for PBS (-) containing 150 microgram / mL neutral red, and culture | cultivated at 37 degreeC for 2 hours. Next, it was replaced with a 50% aqueous ethanol solution containing 1% acetic acid, neutral red incorporated into the cells was extracted, and the absorbance at 540 nm of the extract was measured.
The evaluation results are shown in Table 8 as relative values when the cell viability in the control without addition of t-butyl hydroperoxide is defined as 100.

Figure 0005388555
Figure 0005388555

表8の結果から明らかなように、ハチジョウカグマ(古葉)熱水抽出物(抽出物4)は有意な過酸化脂質耐性効果が認められた。   As is clear from the results of Table 8, the bee brown bear (old leaf) hot water extract (Extract 4) was found to have a significant lipid peroxide resistance effect.

<抗酸化効果(DPPHラジカル消去作用)>
抽出物6を、50質量%エタノールを用いて表9に示した濃度に調整して試料溶液とし、96穴マイクロプレートに100μLずつ添加した。そこへ、0.2mMの1,1−ジフェニル−2−ピクリルヒドラジカル(DPPH)エタノール溶液を100μLずつ添加し、良く混合後、室温、暗所にて24時間静置した。その後、DPPHラジカルに由来する516nmの吸光度を測定した。試料を添加しなかった場合のコントロールの吸光度を(A)、試料を添加した場合の吸光度を(B)としたとき、DPPHラジカルの消去率を式(1)に導入して求めた。測定結果を表9に示す。
式(1):ラジカル消去率={1−(B)/(A)}×100(%)
<Antioxidant effect (DPPH radical scavenging action)>
Extract 6 was adjusted to the concentration shown in Table 9 using 50% by mass ethanol to obtain a sample solution, and 100 μL was added to each 96-well microplate. Thereto was added 100 μL of 0.2 mM 1,1-diphenyl-2-picrylhydride radical (DPPH) ethanol solution, mixed well, and allowed to stand at room temperature in the dark for 24 hours. Thereafter, the absorbance at 516 nm derived from the DPPH radical was measured. When the absorbance of the control when the sample was not added was (A) and the absorbance when the sample was added was (B), the DPPH radical elimination rate was calculated by introducing the formula (1). Table 9 shows the measurement results.
Formula (1): Radical scavenging rate = {1- (B) / (A)} × 100 (%)

Figure 0005388555
Figure 0005388555

表9の結果から明らかなように、ハチジョウカグマ(古葉)超臨界抽出物(抽出物6)は有意なDPPHラジカル消去効果が認められた。   As is clear from the results in Table 9, the bee brown bear (old leaf) supercritical extract (Extract 6) showed a significant DPPH radical scavenging effect.

<抗酸化効果(スーパーオキサイドアニオン消去作用)>
0.25mM WST−1及び1mM ヒポキサンチンを含むHanks(+)溶液75μLに、抽出物4を表10に示す濃度となるようにHanks(+)溶液で希釈した試料25μLを添加し、キサンチンオキシダーゼ25μL(0.0075ユニット)を加え、37℃で15分間反応後、450nmの吸光度を測定した。試料が無添加のコントロールの吸光度を(A)、試料を添加したときの吸光度を(B)としたとき、式(2)の値をスーパーオキサイドアニオン消去率とした。評価結果を表10に示した。
式(2):消去率={1−(B)/(A)}×100(%)
<Antioxidant effect (superoxide anion scavenging action)>
To 75 μL of Hanks (+) solution containing 0.25 mM WST-1 and 1 mM hypoxanthine, 25 μL of a sample obtained by diluting extract 4 with Hanks (+) solution to a concentration shown in Table 10 was added, and xanthine oxidase 25 μL (0.0075 units) was added, and after reacting at 37 ° C. for 15 minutes, the absorbance at 450 nm was measured. When the absorbance of the control to which the sample was not added was (A) and the absorbance when the sample was added was (B), the value of formula (2) was defined as the superoxide anion elimination rate. The evaluation results are shown in Table 10.
Formula (2): Erase rate = {1- (B) / (A)} × 100 (%)

Figure 0005388555
Figure 0005388555

表10の結果から明らかなように、ハチジョウカグマ(古葉)熱水抽出物(抽出物10)は有意なスーパーオキサイドアニオン消去効果が認められた。   As is clear from the results in Table 10, the bee brown bear (old leaf) hot water extract (extract 10) showed a significant superoxide anion scavenging effect.

上述のとおり、ハチジョウカグマ抽出物は、過酸化脂質耐性作用、DPPHラジカル消去作用、およびスーパーオキサイドアニオン消去作用を有し、優れた抗酸化効果を発揮する。   As described above, the bee brown bear extract has a lipid peroxide resistance action, a DPPH radical scavenging action, and a superoxide anion scavenging action, and exhibits an excellent antioxidant effect.

<痩身効果(ヒト前駆脂肪細胞中性脂肪蓄積抑制作用の評価)>
皮下脂肪由来正常ヒト前駆脂肪細胞Cryo HPRAD−SQを1ウェル当り5.0×10個となるように96ウェルマイクロプレートに播種した。播種培地にはPGM培地(10%FBS、2mM L−グルタミン、100ユニット/mL ペニシリン、100μg/mL ストレプトマイシン含有)を用いた。48時間培養後、表11に示す濃度となるように抽出物1を添加したPGM分化用培地(10μg/mL インシュリン、1μM デキサメタゾン、200μM インドメタシン、500μM イソブチルメチルキサンチン含有)に交換し、脂肪細胞への分化誘導を行った。分化誘導開始後、コントロール群が成熟して細胞内に多数の脂肪滴が蓄積されるまで、10〜14日間培養した。細胞を回収後、10%中性緩衝ホルムアルデヒド溶液を用いて細胞を固定した。PBS(−)にて洗浄後、0.5質量/体積%オイルレッドO溶液を添加し、37℃で2時間培養した。PBS(−)にて洗浄後、メタノールを添加し、色素を抽出し、550nmの吸光度を測定した。同時に、濁度として650nmの吸光度を測定し、両測定値の差を用いて中性脂肪蓄積抑制作用を評価した。評価結果を試料無添加のコントロールにおける中性脂肪蓄積量を100とした時の相対値にて表11に示す。
<Slimming effect (Evaluation of neutral fat accumulation inhibitory action of human preadipocytes)>
Subcutaneous fat-derived normal human preadipocytes Cryo HPRAD-SQ were seeded in a 96-well microplate so as to be 5.0 × 10 3 cells per well. PGM medium (containing 10% FBS, 2 mM L-glutamine, 100 units / mL penicillin, 100 μg / mL streptomycin) was used as the seeding medium. After culturing for 48 hours, the medium was exchanged with a PGM differentiation medium (10 μg / mL insulin, 1 μM dexamethasone, 200 μM indomethacin, 500 μM isobutylmethylxanthine) supplemented with extract 1 so as to have the concentration shown in Table 11. Differentiation induction was performed. After initiation of differentiation induction, the cells were cultured for 10 to 14 days until the control group matured and many lipid droplets accumulated in the cells. After harvesting the cells, the cells were fixed using a 10% neutral buffered formaldehyde solution. After washing with PBS (−), 0.5 mass / volume% oil red O solution was added and cultured at 37 ° C. for 2 hours. After washing with PBS (−), methanol was added to extract the dye, and the absorbance at 550 nm was measured. At the same time, the absorbance at 650 nm was measured as turbidity, and the neutral fat accumulation inhibitory action was evaluated using the difference between the two measured values. The evaluation results are shown in Table 11 as relative values when the neutral fat accumulation amount in the control with no sample added is taken as 100.

Figure 0005388555
Figure 0005388555

表11の結果から明らかなように、ハチジョウカグマ(新葉)エタノール抽出物(抽出物1)は有意な中性脂肪蓄積効果が認められ、優れた痩身効果を発揮する。   As is clear from the results in Table 11, the bee brown bear (new leaf) ethanol extract (Extract 1) has a significant triglyceride accumulation effect and exhibits an excellent slimming effect.

<美白効果(ヒト表皮メラニン細胞チロシナーゼ活性阻害作用)>
クラボウ社製正常ヒト表皮メラニン細胞を、1ウェル当たり3.0×10個となるように96ウェルマイクロプレートに播種した。播種培地には、クラボウ社製Medium154Sを用いた。24時間後、Medium154Sによって表12に示す各濃度になるように抽出物4を添加した培地に交換し、さらに48時間培養した。次に、1質量%トリトン−X含有リン酸緩衝液75μLに交換して細胞を完全に溶解させ、内50μLを粗酵素液として使用した。粗酵素液に、基質となる0.05質量%L−ドーパ含有リン酸緩衝液50μLを加え、37℃で2時間静置した。マイクロプレートリーダーにより、基質添加直後と反応終了時の405nmの吸光度を測定し、生成されたドーパメラニン量を、式(3)に各測定値を導入して求めた。
式(3):生成されたドーパメラニン量={(反応後405nm値−反応前405nm値)}−2.166/5.238
また、PIERCE社製BCAプロテインアッセイキットにより各ウェルのタンパク量を測定し、単位タンパク量当たりのドーパメラニン生成量を求めた。コントロールの値を100とした時の相対値より、チロシナーゼ活性阻害作用を評価した。結果を表12に示す。
<Whitening effect (inhibition of human epidermal melanocyte tyrosinase activity)>
Normal human epidermal melanocytes manufactured by Kurabo Industries Co., Ltd. were seeded in a 96-well microplate so as to be 3.0 × 10 4 cells per well. As a seeding medium, Medium154S manufactured by Kurabo Industries Co., Ltd. was used. After 24 hours, the medium was replaced with Medium 154S to which the extract 4 was added so as to have each concentration shown in Table 12, and the culture was further continued for 48 hours. Next, the cells were completely lysed by exchanging with 75 μL of 1% by weight Triton-X-containing phosphate buffer, and 50 μL of the cells was used as a crude enzyme solution. To the crude enzyme solution, 50 μL of 0.05% by mass L-dopa-containing phosphate buffer serving as a substrate was added and allowed to stand at 37 ° C. for 2 hours. The absorbance at 405 nm was measured immediately after the addition of the substrate and at the end of the reaction with a microplate reader, and the amount of dopamelanin produced was determined by introducing each measured value into Equation (3).
Formula (3): Amount of produced dopamelanin = {(405 nm value after reaction−405 nm value before reaction)} − 2.166 / 5.238
In addition, the amount of protein in each well was measured with a BCA protein assay kit manufactured by PIERCE, and the amount of dopamelanin produced per unit protein was determined. Tyrosinase activity inhibitory action was evaluated from the relative value when the control value was 100. The results are shown in Table 12.

Figure 0005388555
Figure 0005388555

表12の結果から明らかなように、ハチジョウカグマ(古葉)熱水抽出物(抽出物4)は有意なチロシナーゼ活性阻害効果が認められた。   As is clear from the results in Table 12, the bee brown bear (old leaf) hot water extract (Extract 4) was found to have a significant tyrosinase activity inhibitory effect.

<美白効果(B16マウスメラノーマ細胞メラニン産生抑制作用の評価)>
B16マウスメラノーマ細胞(B16F0細胞)を1ディッシュ当り18000個となるように90mmディッシュに播種した。播種培地には5質量%のウシ胎児血清(FBS)を添加したダルベッコ改変イーグル培地(DMEM)を用いた。24時間後、5%質量FBS添加DMEM培地にて表13に示す濃度になるように抽出物2を添加した培養液に交換し、さらに5日間培養した。培養終了後、トリプシン処理にて細胞をはがし、1.5mLマイクロチューブに移して遠心操作して細胞沈殿物を得た。得られた沈殿物は下記判定表を基にその黒化状況を肉眼判定した。評価ではネガティブコントロールに5%質量FBS添加DMEM培地、ポジティブコントロールに50mM乳酸ナトリウムを含有する5%質量FBS添加DMEM培地を用いた。これらの肉眼判定結果は判定5及び判定1とし、サンプル判定の指標とした。肉眼判定は下記に示す通り、5段階評価した。また同時に、沈殿物に組織溶解剤(商品名Solvable)を添加して煮沸し、室温に戻して分光光度計(HITACHI製分光光度計U−3010)により500nmの吸光度を測定し、総メラニン量を求めた。評価結果を表13に示す。
判定及び基準
判定 基準
1 ポジティブコントロールと同程度(ほぼ白)
2 ポジティブコントロールより僅かに黒化する(うすい褐色)
3 ポジティブコントロールとネガティブコントロールの中間(褐色)
4 ネガティブコントロールと比べやや黒化が抑制されている(黒褐色) 5 ネガティブコントロールと同程度(ほぼ黒)
<Whitening effect (evaluation of B16 mouse melanoma cell melanin production inhibitory effect)>
B16 mouse melanoma cells (B16F0 cells) were seeded in a 90 mm dish so that there were 18000 cells per dish. Dulbecco's modified Eagle medium (DMEM) supplemented with 5% by weight fetal bovine serum (FBS) was used as the seeding medium. After 24 hours, the medium was replaced with a culture solution to which the extract 2 was added to a concentration shown in Table 13 in a DMEM medium supplemented with 5% mass FBS, and further cultured for 5 days. After completion of the culture, cells were peeled off by trypsin treatment, transferred to a 1.5 mL microtube, and centrifuged to obtain a cell precipitate. The obtained precipitate was visually determined based on the following determination table. In the evaluation, a 5% mass FBS-added DMEM medium containing 5% mass FBS was used as a negative control, and a 5% mass FBS-added DMEM medium containing 50 mM sodium lactate was used as a positive control. These naked eye determination results were determined to be determination 5 and determination 1, and used as an index for sample determination. The naked eye evaluation was evaluated in five stages as shown below. At the same time, the tissue solubilizer (trade name Solvable) was added to the precipitate, boiled, returned to room temperature, and the absorbance at 500 nm was measured with a spectrophotometer (HITACHI spectrophotometer U-3010) to determine the total amount of melanin. Asked. The evaluation results are shown in Table 13.
Judgment and Standard Judgment Criterion 1 Same as positive control (almost white)
2 Slightly darker than the positive control (light brown)
3 Between positive control and negative control (brown)
4 Slightly less blackening than the negative control (blackish brown) 5 Same level as the negative control (almost black)

Figure 0005388555
Figure 0005388555

表13の結果から明らかなように、ハチジョウカグマ(古葉)50%エタノール抽出物(抽出物2)は有意なメラニン産生抑制効果が認められた。   As is clear from the results in Table 13, the bee brown bear (old leaf) 50% ethanol extract (Extract 2) was found to have a significant melanin production inhibitory effect.

ハチジョウカグマ抽出物は、チロシナーゼ阻害活性およびメラニン産生抑制作用を有し、優れた美白効果を発揮する。   The bee brown bear extract has a tyrosinase inhibitory activity and a melanin production inhibitory action, and exhibits an excellent whitening effect.

<抗炎症効果(ヒアルロニダーゼ阻害作用の評価)>
ヒアルロン酸カリウム塩(ヒト臍の緒由来)を0.9mg/mLになるよう0.1Mリン酸緩衝液(pH7.0)に溶解し、基質溶液とした。ヒアルロニダーゼ(ウシ精巣由来)を5,300ユニット/mLとなるよう0.1Mリン酸緩衝液(pH7.0)に溶解し、酵素溶液とした。緩衝液にて表14に示す濃度になるように抽出物2を添加した溶液0.1mLおよび酵素溶液0.03mLを試験管にとり、37℃で20分間反応させた。次に活性化剤を0.06mL加え、37℃で20分間反応させた。さらに基質溶液を0.15mL加え、37℃で1時間反応させた。0.4NのNaOHを0.06mL加え、反応停止後すぐに氷冷し、ホウ酸緩衝液(pH9.1)を0.06mL添加し、3分間煮沸後さらに氷冷した。p−DABA溶液を2.0mL添加し、37℃で20分間反応させた後、反応溶液を96ウェルマイクロプレートに移し、585nmにおける吸光度を測定した。コントロールには、試料無添加の緩衝溶液を用いた。ヒアルロニダーゼの活性が阻害されると分解産物であるN−アセチルグルコサミン(GlcNAc)が減少し、p−DABAによる吸光度が低くなる。ヒアルロニダーゼ阻害作用は次式に定義される。
阻害率(%)=(コントロール吸光度−サンプル吸光度)/コントロール吸光度×100
評価結果を表14に示す。
<Anti-inflammatory effect (evaluation of hyaluronidase inhibitory action)>
Hyaluronic acid potassium salt (derived from human umbilical cord) was dissolved in 0.1 M phosphate buffer (pH 7.0) to a concentration of 0.9 mg / mL to obtain a substrate solution. Hyaluronidase (derived from bovine testis) was dissolved in 0.1 M phosphate buffer (pH 7.0) so as to be 5,300 units / mL to obtain an enzyme solution. 0.1 mL of the solution to which the extract 2 was added and 0.03 mL of the enzyme solution so as to have the concentrations shown in Table 14 in a buffer solution were placed in a test tube and reacted at 37 ° C. for 20 minutes. Next, 0.06 mL of an activator was added and reacted at 37 ° C. for 20 minutes. Further, 0.15 mL of the substrate solution was added and reacted at 37 ° C. for 1 hour. 0.06 mL of 0.4 N NaOH was added, and ice-cooled immediately after the reaction was stopped. Boric acid buffer (pH 9.1) was added in an amount of 0.06 mL, boiled for 3 minutes, and further ice-cooled. After 2.0 mL of p-DABA solution was added and reacted at 37 ° C. for 20 minutes, the reaction solution was transferred to a 96-well microplate, and the absorbance at 585 nm was measured. As a control, a sample-free buffer solution was used. When the activity of hyaluronidase is inhibited, the degradation product N-acetylglucosamine (GlcNAc) decreases, and the absorbance by p-DABA decreases. Hyaluronidase inhibitory action is defined by the following equation.
Inhibition rate (%) = (control absorbance−sample absorbance) / control absorbance × 100
The evaluation results are shown in Table 14.

Figure 0005388555
Figure 0005388555

表14から明らかなように、ハチジョウカグマ(古葉)50%エタノール抽出物(抽出物2)は、有意なヒアルロニダーゼ阻害効果が認められ、優れた抗炎症効果を発揮する。   As is clear from Table 14, a bee brown bear (old leaf) 50% ethanol extract (Extract 2) has a significant hyaluronidase inhibitory effect and exhibits an excellent anti-inflammatory effect.

<免疫賦活効果(ヒト急性単球白血病細胞株を用いた細胞賦活作用)>
ヒト急性単球白血病細胞株(THP−1)を1ウェル当り5.0×104個となるように96ウェルマイクロプレートに播種した。播種培地には1質量%のFBSを添加したRpswell Park Memorial Institute培地(RPMI)を用いた。24時間後、フォルボール 12−ミリステート 13−アセテート(PMA)を20ng/mLとなるように細胞培養液に添加した。さらに24時間後、1質量%FBS添加RPMI培地にて表15に示す各濃度になるように抽出物1を添加した培養液に交換し、48時間培養した。次に生細胞数測定試薬SF(同仁化学研究所)1/10量を添加した1質量%FBS添加RPMI培地を、上清を除いた細胞に添加し、2時間培養した。混合後、450nmの吸光度を測定した。同時に濁度として650nmの吸光度を測定し、両測定値の差を用いて細胞賦活作用を評価した。評価結果を試料無添加のコントロールにおける細胞賦活作用を100とした時の相対値にて表15に示す。
<Immune activation effect (cell activation using human acute monocyte leukemia cell line)>
A human acute monocyte leukemia cell line (THP-1) was seeded on a 96-well microplate so that the number of human acute monocytic leukemia cell line (THP-1) was 5.0 × 10 4 per well. As a seeding medium, Rpswell Park Memorial Institute medium (RPMI) supplemented with 1% by mass of FBS was used. After 24 hours, phorbol 12-myristate 13-acetate (PMA) was added to the cell culture to 20 ng / mL. Further, after 24 hours, the culture medium was added with the extract 1 added to 1% by mass FBS-added RPMI medium so that each concentration shown in Table 15 was obtained, and cultured for 48 hours. Next, RPMI medium supplemented with 1% by mass FBS to which 1/10 amount of living cell count reagent SF (Dojindo Laboratories) was added was added to the cells from which the supernatant had been removed, and cultured for 2 hours. After mixing, the absorbance at 450 nm was measured. At the same time, the absorbance at 650 nm was measured as turbidity, and the cell activation effect was evaluated using the difference between the two measured values. The evaluation results are shown in Table 15 as relative values when the cell activation effect in the control with no sample added is taken as 100.

Figure 0005388555
Figure 0005388555

表15から明らかなように、ハチジョウカグマ(新葉)50%エタノール抽出物(抽出物1)を添加した培地では、有意なヒト急性単球白血病細胞株(免疫細胞)の賦活作用が認められ、優れた免疫賦活効果を発揮する。   As can be seen from Table 15, in the medium supplemented with bee brown bear (new leaf) 50% ethanol extract (Extract 1), a significant human acute monocytic leukemia cell line (immune cell) activation effect was observed, which is excellent. Demonstrate the immunostimulatory effect.

続いて、上記各調製方法で得られたコモチシダ属植物抽出物を配合した皮膚外用剤および機能性経口組成物の処方例を示す。   Then, the formulation example of the skin external preparation and the functional oral composition which mix | blended the Comotochida genus plant extract obtained by said each preparation method is shown.

乳液
(1)スクワラン 10.0(質量%)
(2)メチルフェニルポリシロキサン 4.0
(3)水素添加パーム核油 0.5
(4)水素添加大豆リン脂質 0.1
(5)モノステアリン酸ポリオキシエチレン
ソルビタン(20E.O.) 1.3
(6)モノステアリン酸ソルビタン 1.0
(7)グリセリン 4.0
(8)パラオキシ安息香酸メチル 0.1
(9)カルボキシビニルポリマー 0.15
(10)精製水 100とする残部
(11)アルギニン(1質量%水溶液) 20.0
(12)抽出物1 5.0
製法:(1)〜(6)の油相成分を80℃にて加熱溶解する。一方(7)〜(10)の水相成分を80℃にて加熱溶解する。これに前記油相成分を攪拌しながら加え、ホモジナイザーにより均一に乳化する。冷却後40℃にて、(11)と(12)を順次加え、均一に混合する。
Emulsion (1) Squalane 10.0 (mass%)
(2) Methylphenylpolysiloxane 4.0
(3) Hydrogenated palm kernel oil 0.5
(4) Hydrogenated soybean phospholipid 0.1
(5) Polyoxyethylene monostearate
Sorbitan (20E.O.) 1.3
(6) Sorbitan monostearate 1.0
(7) Glycerin 4.0
(8) Methyl paraoxybenzoate 0.1
(9) Carboxyvinyl polymer 0.15
(10) The balance to be purified water 100 (11) Arginine (1% by mass aqueous solution) 20.0
(12) Extract 1 5.0
Production method: The oil phase components (1) to (6) are heated and dissolved at 80 ° C. On the other hand, the aqueous phase components (7) to (10) are dissolved by heating at 80 ° C. The oil phase component is added to this while stirring and uniformly emulsified with a homogenizer. After cooling, add (11) and (12) sequentially at 40 ° C. and mix uniformly.

化粧水
(1)エタノール 15.0(質量%)
(2)ポリオキシエチレン(40E.O.)硬化ヒマシ油 0.3
(3)香料 0.1
(4)精製水 100とする残部
(5)クエン酸 0.02
(6)クエン酸ナトリウム 0.1
(7)グリセリン 1.0
(8)ヒドロキシエチルセルロース 0.1
(9)抽出物2 1.0
製法:(1)に(2)及び(3)を溶解する。さらに(4)〜(8)を順次添加した後、十分に攪拌し、(9)を加え、均一に混合する。
Lotion (1) Ethanol 15.0 (mass%)
(2) Polyoxyethylene (40E.O.) hydrogenated castor oil 0.3
(3) Fragrance 0.1
(4) Purified water 100 (5) Citric acid 0.02
(6) Sodium citrate 0.1
(7) Glycerin 1.0
(8) Hydroxyethyl cellulose 0.1
(9) Extract 2 1.0
Production method: (2) and (3) are dissolved in (1). Further, after sequentially adding (4) to (8), the mixture is sufficiently stirred, and (9) is added and mixed uniformly.

クリーム
(1)スクワラン 10.0(質量%)
(2)ステアリン酸 2.0
(3)水素添加パーム核油 0.5
(4)水素添加大豆リン脂質 0.1
(5)セタノール 3.6
(6)親油型モノステアリン酸グリセリン 2.0
(7)グリセリン 10.0
(8)パラオキシ安息香酸メチル 0.1
(9)アルギニン(20質量%水溶液) 15.0
(10)精製水 100とする残部
(11)カルボキシビニルポリマー(1質量%水溶液) 15.0
(12)抽出物3 5.0
製法:(1)〜(6)の油相成分を80℃にて加熱溶解する。一方(7)〜(10)の水相成分を80℃にて加熱溶解する。これに前記油相成分を攪拌しながら加え、ホモジナイザーにより均一に乳化する。(11)を添加して攪拌後、冷却し40℃にて(12)を加え、均一に混合する。
Cream (1) Squalane 10.0 (mass%)
(2) Stearic acid 2.0
(3) Hydrogenated palm kernel oil 0.5
(4) Hydrogenated soybean phospholipid 0.1
(5) Cetanol 3.6
(6) Lipophilic glyceryl monostearate 2.0
(7) Glycerin 10.0
(8) Methyl paraoxybenzoate 0.1
(9) Arginine (20 mass% aqueous solution) 15.0
(10) Remainder 100 (11) Carboxyvinyl polymer (1% by weight aqueous solution) 15.0
(12) Extract 3 5.0
Production method: The oil phase components (1) to (6) are heated and dissolved at 80 ° C. On the other hand, the aqueous phase components (7) to (10) are dissolved by heating at 80 ° C. The oil phase component is added to this while stirring and uniformly emulsified with a homogenizer. Add (11), stir, cool and add (12) at 40 ° C. and mix uniformly.

美容液
(1)精製水 100とする残部(質量%)
(2)グリセリン 10.0
(3)ショ糖脂肪酸エステル 1.3
(4)カルボキシビニルポリマー(1質量%水溶液) 17.5
(5)アルギン酸ナトリウム(1質量%水溶液) 15.0
(6)モノラウリン酸ポリグリセリル 1.0
(7)マカデミアナッツ油脂肪酸フィトステリル 3.0
(8)N−ラウロイル−L−グルタミン酸
ジ(フィトステリル−2−オクチルドデシル) 2.0
(9)硬化パーム油 2.0
(10)スクワラン(オリーブ由来) 1.0
(11)ベヘニルアルコール 0.75
(12)ミツロウ 1.0
(13)ホホバ油 1.0
(14)1,3−ブチレングリコール 10.0
(15)L−アルギニン(10質量%水溶液) 2.0
(16)抽出物4 3.0
製法:(1)〜(6)の水相成分を混合し、75℃にて加熱溶解する。一方、(7)〜(14)の油相成分を混合し、75℃にて加熱溶解する。次いで、上記水相成分に油相成分を添加して予備乳化を行った後、ホモミキサーにて均一に乳化する。冷却後50℃にて(15)を、40℃にて(16)を加え、均一に混合する。
Essence (1) Purified water 100 balance (mass%)
(2) Glycerin 10.0
(3) Sucrose fatty acid ester 1.3
(4) Carboxyvinyl polymer (1% by weight aqueous solution) 17.5
(5) Sodium alginate (1% by weight aqueous solution) 15.0
(6) Polyglyceryl monolaurate 1.0
(7) Macadamia nut oil fatty acid phytosteryl 3.0
(8) N-lauroyl-L-glutamic acid di (phytosteryl-2-octyldodecyl) 2.0
(9) Hardened palm oil 2.0
(10) Squalane (from olive) 1.0
(11) Behenyl alcohol 0.75
(12) Beeswax 1.0
(13) Jojoba oil 1.0
(14) 1,3-butylene glycol 10.0
(15) L-arginine (10% by mass aqueous solution) 2.0
(16) Extract 4 3.0
Production method: The aqueous phase components (1) to (6) are mixed and dissolved by heating at 75 ° C. On the other hand, the oil phase components (7) to (14) are mixed and dissolved by heating at 75 ° C. Next, the oil phase component is added to the aqueous phase component and preliminary emulsification is performed, followed by uniform emulsification with a homomixer. After cooling, add (15) at 50 ° C and (16) at 40 ° C and mix uniformly.

水性ジェル
(1)カルボキシビニルポリマー 0.5(質量%)
(2)精製水 100とする残部
(3)水酸化ナトリウム(10質量%水溶液) 0.5
(4)エタノール 10.0
(5)パラオキシ安息香酸メチル 0.1
(6)香料 0.1
(7)抽出物1 0.5
(8)ポリオキシエチレン(60E.O.)硬化ヒマシ油 1.0
製法:(1)を(2)に加え、均一に攪拌した後、(3)を加える。均一に攪拌した後、(4)に予め溶解した(5)を加える。均一に攪拌した後、予め混合しておいた(6)〜(8)を加え、均一に攪拌混合する。
Aqueous gel (1) Carboxyvinyl polymer 0.5 (mass%)
(2) The balance made into purified water 100 (3) Sodium hydroxide (10 mass% aqueous solution) 0.5
(4) Ethanol 10.0
(5) Methyl paraoxybenzoate 0.1
(6) Fragrance 0.1
(7) Extract 1 0.5
(8) Polyoxyethylene (60E.O.) hydrogenated castor oil 1.0
Manufacturing method: (1) is added to (2), and after stirring uniformly, (3) is added. After stirring uniformly, (5) previously dissolved in (4) is added. After stirring uniformly, the previously mixed (6) to (8) are added and stirred and mixed uniformly.

クレンジング料
(1)スクワラン 81.0(質量%)
(2)イソステアリン酸ポリオキシエチレングリセリル 15.0
(3)精製水 100とする残部
(4)抽出物6 4.0
製法:(1)と(2)を均一に溶解する。これに、(3)と(4)を順次加え、均一に混合する。
Cleansing fee (1) Squalane 81.0 (mass%)
(2) Polyoxyethylene glyceryl isostearate 15.0
(3) Remainder to be purified water 100 (4) Extract 6 4.0
Manufacturing method: (1) and (2) are uniformly dissolved. (3) and (4) are sequentially added to this and mixed uniformly.

洗顔フォーム
(1)ステアリン酸 16.0(質量%)
(2)ミリスチン酸 16.0
(3)親油型モノステアリン酸グリセリン 2.0
(4)グリセリン 25.0
(5)水酸化ナトリウム 7.5
(6)ヤシ油脂肪酸アミドプロピルベタイン 1.0
(7)精製水 100とする残部
(8)抽出物2 0.1
製法:(1)〜(4)の油相成分を80℃にて加熱溶解する。一方(5)〜(7)の水相成分を80℃にて加熱溶解し、油相成分と均一に混合撹拌する。冷却後40℃にて(8)を加え、均一に混合する。
Facial cleansing foam (1) Stearic acid 16.0 (mass%)
(2) Myristic acid 16.0
(3) Lipophilic glyceryl monostearate 2.0
(4) Glycerin 25.0
(5) Sodium hydroxide 7.5
(6) Palm oil fatty acid amidopropyl betaine 1.0
(7) The balance which is made into purified water 100 (8) Extract 2 0.1
Production method: The oil phase components (1) to (4) are heated and dissolved at 80 ° C. On the other hand, the aqueous phase components (5) to (7) are heated and dissolved at 80 ° C., and mixed and stirred uniformly with the oil phase components. After cooling, add (8) at 40 ° C. and mix uniformly.

メイクアップベースクリーム
(1)スクワラン 10.2(質量%)
(2)セタノール 2.0
(3)グリセリントリ−2−エチルヘキサン酸エステル 2.5
(4)親油型モノステアリン酸グリセリル 1.0
(5)プロピレングリコール 11.0
(6)ショ糖脂肪酸エステル 1.3
(7)精製水 100とする残部
(8)酸化チタン 1.0
(9)ベンガラ 0.1
(10)黄酸化鉄 0.4
(11)香料 0.1
(12)抽出物3 3.0
製法:(1)〜(4)の油相成分を混合し、75℃にて加熱溶解する。一方、(5)〜(7)の水相成分を混合し、75℃にて加熱溶解し、これに(8)〜(10)の顔料を加え、ホモミキサーにて均一に分散させる。この水相成分に前記油相成分を加え、ホモミキサーにて乳化する。冷却後40℃にて(11)と(12)の成分を加え、均一に混合する。
Makeup base cream (1) Squalane 10.2 (mass%)
(2) Cetanol 2.0
(3) Glycerin tri-2-ethylhexanoate 2.5
(4) Lipophilic glyceryl monostearate 1.0
(5) Propylene glycol 11.0
(6) Sucrose fatty acid ester 1.3
(7) The balance which makes 100 purified water (8) Titanium oxide 1.0
(9) Bengala 0.1
(10) Yellow iron oxide 0.4
(11) Fragrance 0.1
(12) Extract 3 3.0
Production method: The oil phase components (1) to (4) are mixed and dissolved by heating at 75 ° C. On the other hand, the aqueous phase components (5) to (7) are mixed and dissolved by heating at 75 ° C., and the pigments (8) to (10) are added thereto and dispersed uniformly with a homomixer. The oil phase component is added to the water phase component and emulsified with a homomixer. After cooling, add components (11) and (12) at 40 ° C. and mix uniformly.

乳液状ファンデーション
(1)メチルポリシロキサン 2.0(質量%)
(2)スクワラン 5.0
(3)ミリスチン酸オクチルドデシル 5.0
(4)セタノール 1.0
(5)ポリオキシエチレン(20E.O.)
ソルビタンモノステアリン酸エステル 1.3
(6)モノステアリン酸ソルビタン 0.7
(7)1,3−ブチレングリコール 8.0
(8)キサンタンガム 0.1
(9)パラオキシ安息香酸メチル 0.1
(10)精製水 100とする残部
(11)酸化チタン 9.0
(12)タルク 7.4
(13)ベンガラ 0.5
(14)黄酸化鉄 1.1
(15)黒酸化鉄 0.1
(16)香料 0.1
(17)抽出物4 0.5
製法:(1)〜(6)の油相成分を混合し、75℃にて加熱溶解する。一方、(7)〜(10)の水相成分を混合し、75℃にて加熱溶解し、これに(11)〜(15)の顔料を加え、ホモミキサーにて均一に分散する。油相成分を加え、乳化を行う。冷却後40℃にて(16)と(17)の成分を順次加え、均一に混合する。
Emulsion foundation (1) Methylpolysiloxane 2.0 (mass%)
(2) Squalane 5.0
(3) Octyldodecyl myristate 5.0
(4) Cetanol 1.0
(5) Polyoxyethylene (20E.O.)
Sorbitan monostearate 1.3
(6) Sorbitan monostearate 0.7
(7) 1,3-butylene glycol 8.0
(8) Xanthan gum 0.1
(9) Methyl paraoxybenzoate 0.1
(10) The balance of purified water 100 (11) Titanium oxide 9.0
(12) Talc 7.4
(13) Bengala 0.5
(14) Yellow iron oxide 1.1
(15) Black iron oxide 0.1
(16) Fragrance 0.1
(17) Extract 4 0.5
Production method: The oil phase components (1) to (6) are mixed and dissolved by heating at 75 ° C. On the other hand, the aqueous phase components (7) to (10) are mixed and dissolved by heating at 75 ° C., and the pigments (11) to (15) are added thereto and uniformly dispersed with a homomixer. Add oil phase ingredients and emulsify. After cooling, components (16) and (17) are added sequentially at 40 ° C. and mixed uniformly.

油中水型エモリエントクリーム
(1)流動パラフィン 34.0(質量%)
(2)マイクロクリスタリンワックス 2.0
(3)ワセリン 5.0
(4)ジグリセリンオレイン酸エステル 5.0
(5)塩化ナトリウム 1.3
(6)塩化カリウム 0.1
(7)プロピレングリコール 3.0
(8)1,3−ブチレングリコール 5.0
(9)パラオキシ安息香酸メチル 0.1
(10)精製水 100とする残部
(11)香料 0.1
(12)抽出物5 3.0
製法:(5)と(6)を(11)の一部に溶解して50℃とし、50℃に加熱した(4)に撹拌しながら徐々に加える。これを混合した後、70℃にて加熱溶解した(1)〜(3)に均一に分散する。これに(7)〜(9)を(10)の残部に70℃にて加熱溶解したものを撹拌しながら加え、ホモミキサーにて乳化する。冷却後40℃にて(11)と抽出物5を加え、均一に混合する。
Water-in-oil emollient cream (1) Liquid paraffin 34.0 (mass%)
(2) Microcrystalline wax 2.0
(3) Vaseline 5.0
(4) Diglycerin oleate 5.0
(5) Sodium chloride 1.3
(6) Potassium chloride 0.1
(7) Propylene glycol 3.0
(8) 1,3-butylene glycol 5.0
(9) Methyl paraoxybenzoate 0.1
(10) The balance of 100 purified water (11) Fragrance 0.1
(12) Extract 5 3.0
Production method: Dissolve (5) and (6) in a part of (11) to 50 ° C., and gradually add to (4) heated to 50 ° C. with stirring. After mixing this, it disperse | distributes uniformly to (1)-(3) heated and melt | dissolved at 70 degreeC. (7) to (9) are added to the remainder of (10) heated and dissolved at 70 ° C. with stirring, and emulsified with a homomixer. After cooling, add (11) and extract 5 at 40 ° C. and mix uniformly.

パック
(1)精製水 100とする残部(質量%)
(2)ポリビニルアルコール 12.0
(3)エタノール 17.0
(4)グリセリン 9.0
(5)ポリエチレングリコール(平均分子量1000) 2.0
(6)抽出物1 1.0
(7)香料 0.1
製法:(2)と(3)を混合し、80℃に加温した後、80℃に加温した(1)に溶解する。均一に溶解した後、(4)と(5)を加え、攪拌しながら冷却する。40℃にて(6)と(7)を加え、均一に混合する。
Pack (1) Remainder water (100%)
(2) Polyvinyl alcohol 12.0
(3) Ethanol 17.0
(4) Glycerin 9.0
(5) Polyethylene glycol (average molecular weight 1000) 2.0
(6) Extract 1 1.0
(7) Fragrance 0.1
Production method: (2) and (3) are mixed, heated to 80 ° C, and then dissolved in (1) heated to 80 ° C. After evenly dissolving, add (4) and (5) and cool with stirring. Add (6) and (7) at 40 ° C. and mix uniformly.

入浴剤
(1)香料 0.3(質量%)
(2)抽出物2 3.0
(3)炭酸水素ナトリウム 50.0
(4)硫酸ナトリウム 46.7
製法:(1)〜(4)を均一に混合する。
Bath agent (1) Fragrance 0.3 (mass%)
(2) Extract 2 3.0
(3) Sodium bicarbonate 50.0
(4) Sodium sulfate 46.7
Production method: (1) to (4) are mixed uniformly.

ヘアーワックス
(1)ステアリン酸 3.0(質量%)
(2)マイクロクリスタリンワックス 2.0
(3)セチルアルコール 3.0
(4)高重合メチルポリシロキサン 2.0
(5)メチルポリシロキサン 5.0
(6)ポリ(オキシエチレン・オキシプロピレン)
メチルポリシロキサン共重合体 1.0
(7)パラオキシ安息香酸メチル 0.1
(8)1,3−ブチレングリコール 7.5
(9)アルギニン 0.7
(10)精製水 100とする残部
(11)抽出物3 2.0
(12)香料 0.1
製法:(1)〜(6)の油相成分を混合し、75℃にて加熱溶解後する。一方、(7)〜(10)の水相成分を75℃にて加熱溶解し、前記油相成分を加え、ホモミキサーにて乳化する。冷却後40℃にて(11)と(12)の成分を加え、均一に混合する。
Hair wax (1) Stearic acid 3.0 (mass%)
(2) Microcrystalline wax 2.0
(3) Cetyl alcohol 3.0
(4) Highly polymerized methylpolysiloxane 2.0
(5) Methylpolysiloxane 5.0
(6) Poly (oxyethylene / oxypropylene)
Methylpolysiloxane copolymer 1.0
(7) Methyl paraoxybenzoate 0.1
(8) 1,3-butylene glycol 7.5
(9) Arginine 0.7
(10) The balance of 100 purified water (11) Extract 3 2.0
(12) Fragrance 0.1
Production method: The oil phase components (1) to (6) are mixed and heated and dissolved at 75 ° C. On the other hand, the aqueous phase components (7) to (10) are dissolved by heating at 75 ° C., the oil phase component is added, and the mixture is emulsified with a homomixer. After cooling, add components (11) and (12) at 40 ° C. and mix uniformly.

ヘアートニック
(1)エタノール 50.0(質量%)
(2)精製水 100とする残部
(3)抽出物4 3.0
(4)香料 0.1
製法:(1)〜(4)の成分を混合、均一化する。
Hair artic (1) Ethanol 50.0 (mass%)
(2) The balance of purified water 100 (3) Extract 4 3.0
(4) Fragrance 0.1
Production method: Components (1) to (4) are mixed and homogenized.

錠剤
(1)コーンスターチ 44.0(質量%)
(2)結晶セルロース 100とする残部
(3)カルボキシメチルセルロースカルシウム 5.0
(4)無水ケイ酸 0.5
(5)ステアリン酸マグネシウム 0.5
(6)抽出物5 5.0
製法:(1)〜(6)を均一に混合し、打錠機にて圧縮成型して、1錠200mgの錠剤を得る。
Tablet (1) Corn starch 44.0 (mass%)
(2) Crystalline cellulose 100 (3) Carboxymethylcellulose calcium 5.0
(4) Silicic anhydride 0.5
(5) Magnesium stearate 0.5
(6) Extract 5 5.0
Production method: (1) to (6) are uniformly mixed, and compression-molded with a tableting machine to obtain one tablet of 200 mg.

散剤
(1)ケイ酸アルミン酸マグネシウム 95.3(質量%)
(2)カルボキシメチルセルロースカルシウム 100とする残部
(3)抽出物6 4.0
製法:(1)〜(3)の粉体を混合後、粉砕機にて粉砕し、均一に分散する。
Powder (1) Magnesium aluminate silicate 95.3 (% by mass)
(2) Carboxymethylcellulose calcium 100 The remainder (3) Extract 6 4.0
Production method: After the powders (1) to (3) are mixed, they are pulverized by a pulverizer and uniformly dispersed.

キャンデー
(1)白糖 60.0(質量%)
(2)水飴 100とする残部
(3)抽出物1 5.0
(4)香料 適量
製法:(1)と(2)を加熱混合・均一化した後冷却し、70℃にて成分(3)と(4)を添加し、混合均一化した後成型する。
Candy (1) Sucrose 60.0 (mass%)
(2) Remaining as Minamata 100 (3) Extract 1 5.0
(4) Fragrance Appropriate amount Manufacturing method: (1) and (2) are heated, mixed and homogenized, cooled, components (3) and (4) are added at 70 ° C., mixed and homogenized, and then molded.

ドリンク剤
(1)アミノエチルスルホン酸 1000mg
(2)硝酸チアミン 10mg
(3)リン酸リボフラビンナトリウム 5mg
(4)塩酸ピリドキシン 10mg
(5)無水カフェイン 50mg
(6)クエン酸 250mg
(7)D−ソルビトール液 8mg
(8)抽出物2 1000mg
(9)香料 微量
(10)精製水 100mLとする残部
製法:(1)〜(9)を順次(10)に添加し、均一化する。
Drink (1) Aminoethylsulfonic acid 1000mg
(2) Thiamine nitrate 10mg
(3) Riboflavin sodium phosphate 5mg
(4) Pyridoxine hydrochloride 10mg
(5) Anhydrous caffeine 50mg
(6) Citric acid 250mg
(7) D-sorbitol solution 8mg
(8) Extract 2 1000mg
(9) Fragrance Trace amount (10) Purified water 100 mL of the remaining manufacturing method: (1) to (9) are sequentially added to (10) and homogenized.

実施例16〜実施例29に示した皮膚外用剤は、保湿効果、抗老化効果、抗酸化効果、痩身効果、美白効果、抗炎症効果、免疫賦活効果を有する組成物であった。また実施例30〜実施例33に示した機能性経口組成物は保湿効果、抗老化効果、抗酸化効果、痩身効果、美白効果、抗炎症効果、免疫賦活効果を有する組成物であった。   The external preparation for skin shown in Examples 16 to 29 was a composition having a moisturizing effect, an anti-aging effect, an antioxidant effect, a slimming effect, a whitening effect, an anti-inflammatory effect, and an immunostimulatory effect. The functional oral compositions shown in Examples 30 to 33 were compositions having a moisturizing effect, an anti-aging effect, an antioxidant effect, a slimming effect, a whitening effect, an anti-inflammatory effect, and an immunostimulatory effect.

Claims (1)

ハチジョウカグマまたはその抽出物を有効成分とする保湿剤。   A moisturizer comprising bee brown bear or an extract thereof as an active ingredient.
JP2008310359A 2008-12-05 2008-12-05 Moisturizer, anti-aging agent, antioxidant, slimming agent, whitening agent, anti-inflammatory agent, immunostimulant, external preparation for skin, functional oral composition Active JP5388555B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008310359A JP5388555B2 (en) 2008-12-05 2008-12-05 Moisturizer, anti-aging agent, antioxidant, slimming agent, whitening agent, anti-inflammatory agent, immunostimulant, external preparation for skin, functional oral composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008310359A JP5388555B2 (en) 2008-12-05 2008-12-05 Moisturizer, anti-aging agent, antioxidant, slimming agent, whitening agent, anti-inflammatory agent, immunostimulant, external preparation for skin, functional oral composition

Publications (2)

Publication Number Publication Date
JP2010132606A JP2010132606A (en) 2010-06-17
JP5388555B2 true JP5388555B2 (en) 2014-01-15

Family

ID=42344278

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008310359A Active JP5388555B2 (en) 2008-12-05 2008-12-05 Moisturizer, anti-aging agent, antioxidant, slimming agent, whitening agent, anti-inflammatory agent, immunostimulant, external preparation for skin, functional oral composition

Country Status (1)

Country Link
JP (1) JP5388555B2 (en)

Also Published As

Publication number Publication date
JP2010132606A (en) 2010-06-17

Similar Documents

Publication Publication Date Title
JP2008063266A (en) Anti-aging agent, bleaching agent, anti-oxidizing agent and anti-inflammatory agent
JP5557414B2 (en) Moisturizer, cell activator, and whitening agent
JP5306605B2 (en) Topical skin preparation
JP2010150207A (en) Moisturizer, anti-aging agent, antioxidant, neutral fat-accumulation inhibitor, skin whitening agent, anti-inflammatory agent, immunostimulator, skin care preparation, oral medication
JP2008303147A (en) External preparation for skin
JP2008201694A (en) External preparation for skin
JP5312731B2 (en) Topical skin preparation
JP5247548B2 (en) Moisturizer, anti-aging agent, neutral fat accumulation inhibitor, whitening agent, anti-inflammatory agent, topical skin preparation, oral preparation
JP5025201B2 (en) Moisturizer, anti-aging agent, whitening agent, anti-inflammatory agent, and antioxidant
JP5800454B2 (en) External preparation for skin, oral preparation, antioxidant, anti-aging agent, and immunostimulant
JP5610681B2 (en) Neutral fat accumulation inhibitor
JP5388555B2 (en) Moisturizer, anti-aging agent, antioxidant, slimming agent, whitening agent, anti-inflammatory agent, immunostimulant, external preparation for skin, functional oral composition
JP5465037B2 (en) Anti-aging agent, antioxidant, whitening agent, immunostimulant, external preparation for skin and functional oral composition
JP4748962B2 (en) Moisturizer, cell activator, whitening agent, and antioxidant
JP4970442B2 (en) Whitening agent
JP5550929B2 (en) Moisturizer, anti-aging agent, antioxidant, whitening agent, anti-inflammatory agent, topical skin preparation and functional oral composition
JP2011246375A (en) Whitening agent, antioxidant, skin external preparation, and functional oral composition
JP5610846B2 (en) Anti-aging agent, antioxidant, anti-inflammatory agent, whitening agent, moisturizer, external preparation for skin and functional oral composition
JP5202180B2 (en) Moisturizer, immunostimulant, anti-aging agent, whitening agent, antioxidant, slimming agent, external preparation for skin and functional oral composition
JP4480366B2 (en) Cell activator, whitening agent, hyaluronic acid production promoter, collagen production promoter, antioxidant, and skin external preparation
JP5656348B2 (en) Moisturizer, anti-aging agent, antioxidant, immunostimulant, whitening agent, skin external preparation, functional oral composition
JP5265489B2 (en) Moisturizer, anti-aging agent, antioxidant, whitening agent, anti-inflammatory agent, immunostimulant, topical skin preparation, oral preparation
JP5313003B2 (en) Moisturizer
JP2011168559A (en) Antioxidant, anti-inflammatory agent, anti-aging agent, skin care preparation for external use and functional oral composition
JP2009256243A (en) Humectant, antiaging agent, antioxidant, skin care preparation and functional oral composition

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110823

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130528

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130917

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130920

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20131008

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20131008

R150 Certificate of patent or registration of utility model

Ref document number: 5388555

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250